Abstract Details

Title Safety and Tolerability of a Once-Daily, Extended-Release Memantine Formulation (28 mg) in Patients with Moderate to Severe Alzheimer's Disease: Results of a 52-Week Open-Label Trial

Topic Aging and Dementia

Presentation(s) (-)

Poster/Presentation
Number 251

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Sachin Agarwal, MD, MPH (Columbia University Med Center)	Dr. Agarwal has nothing to disclose.
	No disclosure on file
Stephen M. Graham, PhD (Forest Laboratories)	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��